Palisade Capital Management LLC Evolus, Inc. Transaction History

Palisade Capital Management LLC

  • $3.22 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020
SELL
$3.53 - $6.17 $134,196 - $234,558
-38,016 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$3.53 - $12.21 $7,060 - $24,420
2,000 Added 5.55%
38,016 $158,000
Q4 2019

Feb 04, 2020
BUY
$11.58 - $17.37 $58,085 - $87,127
5,016 Added 16.18%
36,016 $438,000
Q3 2019

Nov 06, 2019
SELL
$13.91 - $19.87 $79,287 - $113,259
-5,700 Reduced 15.53%
31,000 $484,000
Q2 2019

Aug 06, 2019
BUY
$13.19 - $28.36 $484,073 - $1.04 Million
36,700 New
36,700 $537,000

Others Institutions Holding EOLS

# of Institutions
168
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Palisade Capital Management LLC Portfolio

Follow Palisade Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email